Published August 2004 | Version v1
Journal article

Effect of Ganfukang on liver function and serum hepatic fibrosis markers levels in SD rats with experimental hepatic fibrosis

  • 1. The First Hospital of Dalian Medical Univ., Dalian (China)
  • 2. The Second Hospital of Dalian Medical Univ., Dalian (China)
  • 3. Pathophysiology Department of Dalian Medical Univ., Dalian (China)

Description

Objective: To observe the effect of Ganfukang on liver function and serum hepatic fibrosis markers levels in SD rats with experimental hepatic fibrosis. Methods: SD rat models of liver fibrosis was induced by CCl4 (n=57). Liver function (GPT, GOT) and serum hepatic fibrosis markers levels (HA, LN, C-IV, PC-III, with RIA) were tested in these models and 10 control rats. Eleven model rats were left untreated, the others were treated with Ganfukang of different concentrations and the above hepatic parameters were again determined after completion of treatment. Results: Lever function was much deteriorated and serum markers levels significantly increased in the model rats (vs controls, P<0.01). After treatment with Ganfukang, the improvement was significant (vs untreated models, P<0.01). Conclusion: Ganfukang is of definite therapeutic value for experimental hepatic fibrosis in rat models. (authors)

Additional details

Publishing Information

Journal Title
Journal of Radioimmunology
Journal Volume
17
Journal Issue
4
Journal Page Range
p. 283-284
ISSN
1008-9810

Optional Information

Notes
3 tabs., 3 refs.